NCT01631565
- Conditions
- Lung Diseases, Lung Neoplasms, Neoplasms, +4 more
- Locations
-
- National Cancer Institute- México Mexico City, Mexico
Clinical trial condition
Respiratory Tract Neoplasms
Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.
8,109 public trials
1,857 recruiting studies
Respiratory Tract Neoplasms trial results
NCT02972216
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +15 more
- Locations
-
Not specified
NCT00124280
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Nevada Cancer Institute Las Vegas, Nevada, United States
- MD Anderson Cancer Center, Department of Thoracic /Head and Neck Medical Oncology Houston, Texas, United States
Completed
Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
NCT00154388
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +121 more
- Locations
-
Not specified
Completed
BIBF 1120 + Docetaxel (Japan) in Patients With Advanced Non-small-cell Lung Cancer, Phase I
NCT00876460
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
- Locations
-
- 1199.29.002 Boehringer Ingelheim Investigational Site Fukuoka, Fukuoka, Japan
- 1199.29.001 Boehringer Ingelheim Investigational Site Osaka-Sayamashi, Osaka, Japan
NCT02245295
- Conditions
- Lung Cancer, Lung Diseases, Lung Neoplasms, +5 more
- Locations
-
- University Hospital Zurich Zurich, Canton of Zurich, Switzerland
NCT02309567
- Conditions
- Gene, p53, Lung Diseases, Lung Neoplasms, +5 more
- Locations
-
- Cumhuriyet University, School of Medicine, department of Nuclear Medicine Sivas, Campus, Turkey (Türkiye)
NCT01814553
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
- Locations
-
- 1200.167.01009 Boehringer Ingelheim Investigational Site Santa Rosa, California, United States
- 1200.167.01020 Boehringer Ingelheim Investigational Site Orlando, Florida, United States
- 1200.167.01018 Boehringer Ingelheim Investigational Site Port Saint Lucie, Florida, United States
- 1200.167.01012 Boehringer Ingelheim Investigational Site St. Petersburg, Florida, United States
Completed
Erlotinib Hydrochloride and Quinacrine Dihydrochloride in Stage IIIB-IV Non-Small Cell Lung Cancer
NCT01839955
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Cleveland, Ohio, United States
NCT00897442
- Conditions
- Adenoma, Adnexal Diseases, Borderline Ovarian Clear Cell Tumor, +143 more
- Locations
-
- Highlands Oncology Group PA - Fayetteville Fayetteville, Arkansas, United States
- Washington Regional Medical Center - Fayetteville Fayetteville, Arkansas, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States